# Exagen Inc. (XGN)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/XGN/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 17.31M | $ -3.97M | $ -10.65M | N/A | $ 14.43M |
| 2025 | $ 68.17M | $ -20.43M | $ -14.61M | $ 27.67M | $ 17.45M |
| 2024 | $ 58.48M | $ -15.89M | $ -14.50M | $ 23.01M | $ 9.54M |
| 2023 | $ 56.82M | $ -25.61M | $ -16.53M | $ 23.23M | $ 22.69M |
| 2022 | $ 50.90M | $ -52.94M | $ -40.73M | $ 35.20M | $ 42.46M |
| 2021 | $ 57.41M | $ -31.92M | $ -26.91M | $ 28.07M | $ 84.94M |
| 2020 | $ 53.47M | $ -21.26M | $ -18.52M | $ 26.97M | $ 41.84M |
| 2019 | $ 52.13M | $ -15.54M | $ -13.05M | $ 26.09M | $ 55.66M |
| 2018 | $ 42.84M | $ -16.98M | $ -12.55M | $ 24.70M | $ -6.73M |
| 2015 | $ 25.20M | $ -26.93M | $ -17.84M | $ 25.90M | $ -22.18M |
| 2014 | $ 16.48M | $ -21.17M | $ -16.14M | $ 18.52M | $ -14.06M |
| 2013 | $ 4.34M | $ -20.88M | $ -10.01M | $ 8.92M | $ 451.0K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.34 |
| Liabilities / Eq | 2.60 |
| Current Ratio | 3.47 |

## Other views

- [Metrics](https://sponda.capital/en/XGN.md)
- [Charts](https://sponda.capital/en/XGN/charts.md)
- [Compare](https://sponda.capital/en/XGN/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.